Menu
Search
|

Menu

Close
X

China Resources Double-Crane Pharmaceutical Co Ltd 600062.SS (Shanghai Stock Exchange)

12.60 CNY
-0.57 (-4.33%)
As of Jul 19
Previous Close 13.17
Open 12.97
Volume 12,348,908
3m Avg Volume 12,790,799
Today’s High 13.04
Today’s Low 12.56
52 Week High 20.21
52 Week Low 10.66
Shares Outstanding (mil) 869.36
Market Capitalization (mil) 18,300.13
Forward P/E 22.83
Dividend (Yield %) 0.08 ( 0.39 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.83 Mean rating from 6 analysts

KEY STATS

Revenue (mm, CNY)
FY19
2,633
FY18
8,225
FY17
6,422
FY16
5,495
EPS (CNY)
FY19
0.315
FY18
0.928
FY17
0.808
FY16
0.663
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.83
32.67
Price to Sales (TTM)
vs sector
3.20
7.92
Price to Book (MRQ)
vs sector
2.56
5.39
Price to Cash Flow (TTM)
vs sector
--
24.37
Total Debt to Equity (MRQ)
vs sector
0.14
14.56
LT Debt to Equity (MRQ)
vs sector
0.00
10.21
Return on Investment (TTM)
vs sector
11.96
14.49
Return on Equity (TTM)
vs sector
11.84
15.79

EXECUTIVE LEADERSHIP

Yanxi Fan
Vice President, Secretary of the Board, Director, Since 2012
Salary: --
Bonus: --
Zhiyong Ge
Vice President, Since 2005
Salary: --
Bonus: --
Jun Ni
Vice President, Since 2012
Salary: --
Bonus: --
Shunting Yu
Vice President, Since
Salary: --
Bonus: --
Wenduo Wu
Deputy General Manager, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.1 Li Ze East Second Road
Wangjing Area, Chaoyang District
BEIJING   BEJ   100102

Phone: +8610.64398099
Site: www.dcpc.com

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly provides products for lowering blood pressure, blood fat and blood glucose. Specialist segment mainly involves in the research, development and distribution of pharmaceuticals targeting six areas, including cardiovascular and cerebrovascular, pediatrics, kidney disease, mental/nerve, anesthesia and analgesia and respiratory areas. Infusion segment various types of infusion products, such as basic infusion, therapeutic infusion and nutritional. The Company distributes its products mainly in domestic market.

SPONSORED STORIES